| Title | Author(s) | Year | View Count |  | Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection | Ma, H; Kien, F; Manière, M; Zhang, Y; Lagarde, N; Tse, KS; Poon, LLM; Nal, B | 2012 | 80 |
| Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses | Kudelko, M; Brault, JB; Kwok, K; Li, MY; Pardigon, N; Peiris, JSM; Bruzzone, R; Despre, P; Nal, B; Wang, PG | 2012 | 91 |
 | SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. | Jaume, M; Yip, MS; Kam, YW; Cheung, CY; Kien, F; Roberts, A; Li, PH; Dutry, I; Escriou, N; Daeron, M; Bruzzone, R; Subbarao, K; Peiris, JS; Nal, B; Altmeyer, R | 2012 | 65 |
| Identification of human annexin A6 as a novel cellular interactant of influenza A virus M2 protein and regulator of virus budding andrelease | Ma, Huailiang.; 马怀良. | 2012 | 97 |
| Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fcγr pathway | Jaume, M; Yip, MS; Cheung, CY; Leung, HL; Li, PH; Kien, F; Dutry, I; Callendret, B; Escriou, N; Altmeyer, R; Nal, B; Daëron, M; Bruzzone, R; Peiris, JSM | 2011 | 159 |
| Identification of a novel interaction between the M2 protein of influenza A virus and cyclin D3 | Zhang, Yang; 张阳 | 2011 | 194 |
| The SARS coronavirus envelope protein E targets the PALS1 tight junction factor and alters formation of tight junctions of epithelialcells | Chan, Wing-lim.; 陳穎廉. | 2011 | 116 |
| The E envelope protein of the SARS coronavirus interacts with the pals1 tight junction protein through its PDZ domain | Teoh, Kim Tat.; 張錦達. | 2010 | 375 |
| Host cell susceptibility to human coronavirus infections | Millet, Jean Kaoru Guillaume. | 2010 | 395 |
 | Identification of molecular determinants for efficient H5pp production | Lam, YM; Tang, D; Chu, SL; Nal-Rogier, BTM; Bruzzone, R; Lam, CHP | 2010 | 81 |
| The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis | Teoh, KT; Siu, YL; Chan, WL; Schlüter, MA; Liu, CJ; Peiris, JSM; Bruzzone, R; Margolis, B; Nal, B | 2010 | 168 |
| Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins | Wang, PG; Kudelko, M; Lo, J; Yu Lam Siu, L; Tsz Hin Kwok, K; Sachse, M; Nicholls, JM; Bruzzone, R; Altmeyer, RM; Nal, B | 2009 | 121 |
| Coronin-1A links cytoskeleton dynamics to TCRαβ-induced cell signaling | Mugnier, B; Nal, B; Verthuy, C; Boyer, C; Lam, D; Chasson, L; Nieoullon, V; Chazal, G; Guo, XJ; He, HT; RueffJuy, D; Alcover, A; Ferrier, P | 2008 | 325 |
| The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles | Siu, YL; Teoh, KT; Lo, J; Chan, CM; Kien, F; Escriou, N; Tsao, SW; Nicholls, JM; Altmeyer, R; Peiris, JSM; Bruzzone, R; Nal, B | 2008 | 205 |
| H5-type influenza hemagglutinin is functionally recognized by the natural killer activating receptor, Nkp44 | Ho, JWY; Hershkovitz, O; Peiris, M; Zilka, A; Bar-Ilan, A; Nal, B; Chu, K; Kudelko, M; Kam, YW; Achdout, H; Mandelboim, M; Altmeyer, R; Mandelboim, O; Bruzzone, R; Porgador, A | 2008 | 93 |
| H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44 | Ho, JW; Hershkovitz, O; Peiris, M; Zilka, A; BarIlan, A; Nal, B; Chu, K; Kudelko, M; Yiu, WK; Achdout, H; Mandelboim, M; Altmeyer, R; Mandelboim, O; Bruzzone, R; Porgador, A | 2008 | 202 |
| Biochemical, functional and immunogenic characterisation of the SARS spike glycoprotein | Kam, Yiu-wing.; 甘曜榮. | 2007 | 265 |
| Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro | Kam, YW; Kien, F; Roberts, A; Cheung, YC; Lamirande, EW; Vogel, L; Chu, SL; Tse, J; Guarner, J; Zaki, SR; Subbarao, K; Peiris, M; Nal, B; Altmeyer, R | 2007 | 319 |
| High Throughput Screening technological platform: Application to drug discovery, sero-diagnosis and cellular biology research | Garcia, J; Nefkens, I; Choi, PS; Lagarde, NJC; Tang, D; Zuo, JP; Nan, F; Li, J; Vanhoutte, PMGR; Nal-Rogier, BTM; Bruzzone, R; Peiris, JSM; Altmeyer, RM | 2006 | 101 |
| Development of High Throughput Screening platform. Application to drug discovery and Sero-diagnosis. | Garcia, J; Nefkens, I; Choi, PS; Tang, D; Zuo, JP; Nan, F; Li, J; Nal-Rogier, BTM; Peiris, JSM; Altmeyer, RM | 2006 | 101 |
|
